Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Plasmodium is a genus of unicellular eukaryotic parasites that cause malaria. The parasite has a complex life cycle involving multiple stages in both mosquito and human hosts. Each stage presents distinct molecular targets for drug intervention. Targeting molecules essential across multiple stages offers potential for drugs with prophylactic, curative, or transmission-blocking effects.
Varies depending on the drug and the target. Examples include inhibition of parasite enzymes, disruption of parasite membranes, and interference with DNA replication.
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Plasmodium species (Multiple Life Stages) (Plasmodium spp.).